Propensity Score-Matched Analysis Comparing Robotic and Laparoscopic Right and Extended Right Hepatectomy.


Journal

JAMA surgery
ISSN: 2168-6262
Titre abrégé: JAMA Surg
Pays: United States
ID NLM: 101589553

Informations de publication

Date de publication:
01 05 2022
Historique:
pubmed: 10 3 2022
medline: 18 5 2022
entrez: 9 3 2022
Statut: ppublish

Résumé

Laparoscopic and robotic techniques have both been well adopted as safe options in selected patients undergoing hepatectomy. However, it is unknown whether either approach is superior, especially for major hepatectomy such as right hepatectomy or extended right hepatectomy (RH/ERH). To compare the outcomes of robotic vs laparoscopic RH/ERH. In this case-control study, propensity score matching analysis was performed to minimize selection bias. Patients undergoing robotic or laparoscopic RH/EHR at 29 international centers from 2008 to 2020 were included. Robotic vs laparoscopic RH/ERH. Data on patient demographics, tumor characteristics, and short-term perioperative outcomes were collected and analyzed. Of 989 individuals who met study criteria, 220 underwent robotic and 769 underwent laparoscopic surgery. The median (IQR) age in the robotic RH/ERH group was 61.00 (51.86-69.00) years and in the laparoscopic RH/ERH group was 62.00 (52.03-70.00) years. Propensity score matching resulted in 220 matched pairs for further analysis. Patients' demographics and tumor characteristics were comparable in the matched cohorts. Robotic RH/ERH was associated with a lower open conversion rate (19 of 220 [8.6%] vs 39 of 220 [17.1%]; P = .01) and a shorter postoperative hospital stay (median [IQR], 7.0 [5.0-10.0] days; mean [SD], 9.11 [7.52] days vs median [IQR], 7.0 [5.75-10.0] days; mean [SD], 9.94 [8.99] days; P = .048). On subset analysis of cases performed between 2015 and 2020 after a center's learning curve (50 cases), robotic RH/ERH was associated with a shorter postoperative hospital stay (median [IQR], 6.0 [5.0-9.0] days vs 7.0 [6.0-9.75] days; P = .04) with a similar conversion rate (12 of 220 [7.6%] vs 17 of 220 [10.8%]; P = .46). Robotic RH/ERH was associated with a lower open conversion rate and shorter postoperative hospital stay compared with laparoscopic RH/ERH. The difference in open conversion rate was associated with a significant decrease for laparoscopic but not robotic RH/ERH after a center had mounted the learning curve. Use of robotic platform may help to overcome the initial challenges of minimally invasive RH/ERH.

Identifiants

pubmed: 35262660
pii: 2789723
doi: 10.1001/jamasurg.2022.0161
pmc: PMC8908223
mid: NIHMS1791140
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

436-444

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Investigateurs

Mizelle D'Silva (M)
Henri Schotte (H)
Celine De Meyere (C)
Felix Krenzien (F)
Prashant Kadam (P)
Roberto Montalti (R)
Mariano Giglio (M)
Diana Salimgereeva (D)
Ruslan Alikhanov (R)
Lip Seng Lee (LS)
Mikel Prieto (M)
Jae Young Jang (JY)
Paulo Magistri (P)
Kevin P Labadie (KP)
Phan Phuoc Nghia (PP)
Masayuki Kojima (M)
Yutaro Kato (Y)
Paulo Herman (P)
Jaime A P Kruger (JAP)
Nicholas Syn (N)

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Auteurs

Charing C Chong (CC)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.

David Fuks (D)

Department of Digestive, Oncologic and Metabolic Surgery, Institute Mutualiste Montsouris, Universite Paris Descartes, Paris, France.

Kit-Fai Lee (KF)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.

Joseph J Zhao (JJ)

Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital and Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Gi Hong Choi (GH)

Division of Hepatopancreatobiliary Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Iswanto Sucandy (I)

AdventHealth Tampa, Digestive Health Institute, Tampa, Florida.

Adrian K H Chiow (AKH)

Hepatopancreatobiliary Unit, Department of Surgery, Changi General Hospital, Singapore.

Marco V Marino (MV)

General Surgery Department, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy and Oncologic Surgery Department, P. Giaccone University Hospital, Palermo, Italy.

Mikel Gastaca (M)

Hepatobiliary Surgery and Liver Transplantation Unit, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Bilbao, Spain.

Xiaoying Wang (X)

Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.

Jae Hoon Lee (JH)

Department of Surgery, Division of Hepato-Biliary and Pancreatic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Mikhail Efanov (M)

Department of Hepato-Pancreato-Biliary Surgery, Moscow Clinical Scientific Center, Moscow, Russia.

T Peter Kingham (TP)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Mathieu D'Hondt (M)

Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital, Kortrijk, Belgium.

Roberto I Troisi (RI)

Department of Clinical Medicine and Surgery, Division of HPB, Minimally Invasive and Robotic Surgery, Federico II University Hospital Naples, Naples, Italy.

Sung-Hoon Choi (SH)

Department of General Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.

Robert P Sutcliffe (RP)

Department of Hepatopancreatobiliary and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.

Chung-Yip Chan (CY)

Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital and Duke-National University Singapore Medical School, Singapore.

Eric C H Lai (ECH)

Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.

James O Park (JO)

Hepatobiliary Surgical Oncology, Department of Surgery, University of Washington Medical Center, Seattle.

Fabrizio Di Benedetto (F)

Hepatopancreatobiliary Surgery and Liver Transplant Unit, University of Modena and Reggio Emilia, Modena, Italy.

Fernando Rotellar (F)

HPB and Liver Transplant, Department of General Surgery, Clinica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain.
Institute of Health Research of Navarra (IdisNA), Pamplona, Spain.

Atsushi Sugioka (A)

Department of Surgery, Fujita Health University School of Medicine, Aichi, Japan.

Fabricio Ferreira Coelho (FF)

Liver Surgery Unit, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.

Alessandro Ferrero (A)

Department of HPB and Digestive Surgery, Ospedale Mauriziano Umberto I, Turin, Italy.

Tran Cong Duy Long (TCD)

HPB Surgery Department, University Medical Center, HCMC, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Chetana Lim (C)

Department of Digestive, HBP and Liver Transplantation, Hopital Pitie-Salpetriere, APHP, Sorbonne Université, Paris, France.

Olivier Scatton (O)

Department of Digestive, HBP and Liver Transplantation, Hopital Pitie-Salpetriere, APHP, Sorbonne Université, Paris, France.

Qu Liu (Q)

Faculty of Hepatopancreatobiliary Surgery, The First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Moritz Schmelzle (M)

Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin, Corporate Member of Freie Universität Berlin, and Berlin Institute of Health, Berlin, Germany.

Johann Pratschke (J)

Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin, Corporate Member of Freie Universität Berlin, and Berlin Institute of Health, Berlin, Germany.

Tan-To Cheung (TT)

Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.

Rong Liu (R)

Faculty of Hepatopancreatobiliary Surgery, The First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Ho-Seong Han (HS)

Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.

Chung Ngai Tang (CN)

Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.

Brian K P Goh (BKP)

Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital and Duke-National University Singapore Medical School, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH